Genome editing in maize directed by CRISPR–Cas9 ribonucleoprotein complexes

Targeted DNA double-strand breaks have been shown to significantly increase the frequency and precision of genome editing. In the past two decades, several double-strand break technologies have been developed. CRISPR–Cas9 has quickly become the technology of choice for genome editing due to its simp...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications Vol. 7; no. 1; pp. 13274 - 7
Main Authors: Svitashev, Sergei, Schwartz, Christine, Lenderts, Brian, Young, Joshua K., Mark Cigan, A.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 16-11-2016
Nature Publishing Group
Nature Portfolio
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Targeted DNA double-strand breaks have been shown to significantly increase the frequency and precision of genome editing. In the past two decades, several double-strand break technologies have been developed. CRISPR–Cas9 has quickly become the technology of choice for genome editing due to its simplicity, efficiency and versatility. Currently, genome editing in plants primarily relies on delivering double-strand break reagents in the form of DNA vectors. Here we report biolistic delivery of pre-assembled Cas9–gRNA ribonucleoproteins into maize embryo cells and regeneration of plants with both mutated and edited alleles. Using this method of delivery, we also demonstrate DNA- and selectable marker-free gene mutagenesis in maize and recovery of plants with mutated alleles at high frequencies. These results open new opportunities to accelerate breeding practices in a wide variety of crop species. Genome editing in plants typically requires the expression of Cas9 and guide RNA from stably transformed plasmid DNA. Here, the authors show that successful editing can be achieved after delivery of the Cas9-guide RNA complex as a ribonucleoprotein to maize embryos via biolistics.
Bibliography:Present address: Genus Research, Genus plc, DeForest, WI 53532, USA
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms13274